申请人:Bayer Aktiengesellschaft
公开号:US04925865A1
公开(公告)日:1990-05-15
Combating mycoses in humans and other animals with hydroxyalkyl-azolyl derivatives of the formula ##STR1## in which R stands for hydrogen, alkyl or acyl, R.sup.1 stands for halogen, optionally substituted phenyl or the --Z--R.sup.3 grouping, R.sup.2 stands for optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted naphthyl, for the radical of the formula ##STR2## or for the radical of the formula ##STR3## X stands for nitrogen or a CH group and Y stands for the --CH.sub.2 --CH.sub.2 --, --CH.dbd.CH--, --C.tbd.C--, ##STR4## groupings, wherein R.sup.5, R.sup.6, R.sup.7 and R.sup.8 independently of one another stand for hydrogen or alkyl having 1 to 4 carbon atoms, and their acid addition salts.
使用羟基烷基-唑基衍生物对人类和其他动物的真菌病进行治疗,其化学式为##STR1##,其中R代表氢、烷基或酰基,R.sup.1代表卤素、可选择取代的苯基或--Z--R.sup.3基团,R.sup.2代表可选择取代的烷基、可选择取代的环烷基、可选择取代的萘基,或者化学式##STR2##的基团,或者化学式##STR3##的基团,X代表氮或CH基团,Y代表--CH.sub.2 --CH.sub.2 --、--CH.dbd.CH--、--C.tbd.C--、##STR4##等基团,其中R.sup.5、R.sup.6、R.sup.7和R.sup.8独立地代表氢或含有1至4个碳原子的烷基,以及它们的酸盐。